Skip to main content
. 2019 Nov 15;9:1224. doi: 10.3389/fonc.2019.01224

Table 7.

Leukemia/Lymphoma: included studies evaluating the use of RT for LMD.

References Study type Study Pop with LMD (n) Treatment era (years) Median age, years Treatment Median OS (months) Conclusions
Currie et al. (74) Obs 3 1988 63 100% FBRT NR
  • RT leads to considerable clinical improvement

Milgrom et al. (75) Obs 44 2006–2016 NR 95% WBRT; 2% CSI; 70% C 7
  • RT has high response rates

RT, radiotherapy; LMD, leptomeningeal disease; Pop, population; Obs, observational study; PP, practice patterns; NR, not reported; BSC, best supportive care; C, chemotherapy alone; ITC, intrathecal chemotherapy; WBRT, whole brain radiotherapy; FSRT, spine RT; CSI, craniospinal RT.